EUVIMEDEUVIMED entdecken
Crossref

Structural basis for DCAF2 as a novel E3 ligase for PROTAC-mediated targeted protein degradation

Evan J McMahon, Alexander G Cioffi, Patrick R Visperas, Yueqing Lin, Michael Shaghafi, Courtney M Daczkowski, Johannes C Hermann, Robert A Everley, Richard M Neve, Daniel A Erlanson, Kevin R Webster, Vikram Narayan und 1 weitere

Structure · 2025-12 · 33 (12) · 2020-2028.e7

DOI: 10.1016/j.str.2025.09.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Structure, 2025-12. Verfasst von Evan J McMahon und 12 weiteren Autor:innen. Beteiligte Einrichtung: Frontier Medicines, 151 Oyster Point Boulevard, South San Francisco, CA 94080, USA. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, DNA-Binding Proteins. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin-Protein LigasesDNA-Binding ProteinsHumansProteolysisCryoelectron MicroscopyProtein BindingUbiquitinationCell Cycle ProteinsTranscription FactorsModels, MolecularNuclear ProteinsBinding SitesBromodomain Containing Proteins

Stichwörter der Autor:innen

BRD4 degradationCullin4-RING ligaseDCAF2E3 ligasePROTACcryogenic electron microscopyprotein structuretargeted protein degradationubiquitination

Substanzen

DDB1 protein, humanUbiquitin-Protein LigasesDNA-Binding ProteinsCell Cycle ProteinsBRD4 protein, humanTranscription FactorsDTL protein, humanNuclear ProteinsBromodomain Containing Proteins

Autor:innen und Institutionen

  • Frontier Medicines, 151 Oyster Point Boulevard, South San Francisco, CA 94080, USA.
  • Frontier Medicines, 451 D Street, Suite 207, Boston, MA 02210, USA.
  • Frontier Medicines, 151 Oyster Point Boulevard, South San Francisco, CA 94080, USA. Electronic address: vikram.narayan@gmail.com.
  • Frontier Medicines, 151 Oyster Point Boulevard, South San Francisco, CA 94080, USA. Electronic address: weiru.wang@frontiermeds.com.

Zitieren

APA

McMahon, E. J., Cioffi, A. G., Visperas, P. R., Lin, Y., Shaghafi, M., Daczkowski, C. M., Hermann, J. C., Everley, R. A., Neve, R. M., Erlanson, D. A., Webster, K. R., Narayan, V., & Wang, W. (2025). Structural basis for DCAF2 as a novel E3 ligase for PROTAC-mediated targeted protein degradation. Structure, 33(12), 2020-2028.e7. https://doi.org/10.1016/j.str.2025.09.006

Vancouver

McMahon EJ, Cioffi AG, Visperas PR, Lin Y, Shaghafi M, Daczkowski CM, et al. Structural basis for DCAF2 as a novel E3 ligase for PROTAC-mediated targeted protein degradation. Structure. 2025;33(12):2020-2028.e7. doi:10.1016/j.str.2025.09.006

BibTeX
@article{McMahon2025,
  author = {McMahon, Evan J and Cioffi, Alexander G and Visperas, Patrick R and Lin, Yueqing and Shaghafi, Michael and Daczkowski, Courtney M and Hermann, Johannes C and Everley, Robert A and Neve, Richard M and Erlanson, Daniel A and Webster, Kevin R and Narayan, Vikram and Wang, Weiru},
  title = {Structural basis for DCAF2 as a novel E3 ligase for PROTAC-mediated targeted protein degradation},
  journal = {Structure},
  year = {2025},
  volume = {33},
  number = {12},
  pages = {2020--2028.e7},
  doi = {10.1016/j.str.2025.09.006}
}
Kostenlos starten →